DrugPatentWatch Database Preview
Jubilant Generics Company Profile
» See Plans and Pricing
What is the competitive landscape for JUBILANT GENERICS, and what generic and branded alternatives to JUBILANT GENERICS drugs are available?
JUBILANT GENERICS has thirty-eight approved drugs.
Summary for Jubilant Generics
| US Patents: | 0 |
| Tradenames: | 34 |
| Ingredients: | 33 |
| NDAs: | 38 |
Drugs and US Patents for Jubilant Generics
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jubilant Generics | ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 202279-002 | Nov 20, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | FELODIPINE | felodipine | TABLET, EXTENDED RELEASE;ORAL | 203983-003 | Aug 19, 2016 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 203150-001 | Nov 26, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 200221-004 | Sep 12, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | ZOLMITRIPTAN | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 202956-001 | Sep 17, 2015 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Jubilant Generics | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | CAPSULE;ORAL | 209605-002 | Aug 4, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
